![]() |
About Urch News Articles Contact Publications list Consulting |
|
||||||
| search site (& ISBN) | ||||||||
|
News & Press Releases 5 November 2007 URCH Publishing announces launch of Pharmaceutical Market Trends 2nd Edition report A vital reference work for all pharmaceutical executives 23 October 2007 Generics Companies Eye European M&A Targets Ratiopharm, Stada and Actavis identified as likely to make further strategic acquisitions, says URCH report. 16 August 2007 Global cardiovascular drug market to hit $116.3billion by 2010 forecasts URCH Publishing The global cardiovascular drug market is forecast to expand to US$116.3 billion in 2010, says a new report from URCH Publishing 06 June 2007 Patent expiries threaten $22bn of CNS drug sales GSK and J&J’s products likely to be hardest hit by generics predicts URCH report. 20 February 2007 $100 billion of US and European pharmaceutical company revenues threatened by generic drugs forecasts URCH Publishing Generics grow to capture 14% of the global healthcare market 5 December 2006 Innovative biologics will drive sales of cancer drugs over next four years Genentech and Roche likely to enjoy best growth says URCH report 21 June 2006 Blockbusters drugs account for a third of global pharmaceutical sales URCH report highlights reliance big pharma has on billion dollar sellers 24 May 2006 URCH Publishing launches comprehensive overview of pharmaceutical pricing systems in MENA region Today, URCH Publishing announces the publication of a series of briefings on the pricing and reimbursement systems in nine major MENA (Middle East & North Africa) markets 6 April 2006 Economic liberalisation will drive Middle East pharma market size to more than $12bn by 2010. Recent policies to liberalise the economy and the introduction of mass health insurance will spur pharmaceutical growth in key markets over the next five years. 23 November 2005 URCH Publishing launches comprehensive guide to pharmaceutical pricing systems in Western Europe Reference report that will become a vital component in the way executives understand the pricing and reimbursement of pharmaceutical products. 29 September 2005 $60 billion of pharmaceutical company revenues under threat from generic drugs Up to $60 billion of major branded drugs sales are at risk from generic competition between now and 2009 20 September 2004 The Last Bastion: U.S. Pharmaceutical Prices Under Pressure Companies selling pharmaceutical products in the United States could see increasing controls on their products' prices 5 July 2004 No recovery in Pharmaceutical Fine Chemicals market until 2005 The market for pharmaceutical fine chemicals will remain static until 2005 and overcapacity 19 May 2004 EU expansion hinders development of a single European market for pharmaceuticals A SINGLE EUROPEAN market for pharmaceuticals will be hindered by the recent expansion of the European Union 18 February 2004 Urch Publishing: New report on global pharmaceutical Research and Development Assess the key factors critical to long-term success October 2003 Spectre of parallel trade looms large for the global pharmaceutical industry As pharmaceutical companies look for new ways to maximise their revenue, the growing trend of parallel trade threatens to counter their efforts September 2003 Novel drug delivery systems breathe new life into therapeutic peptides Advances in drug delivery technology will contribute to a revival in the development of peptides as therapeutic agents June 2003 Falling investment into pharmaceutical manufacturing risks non-compliance with regulations Failure to comply with GMP may result in financial penalties October 2002 Urch launches comprehensive report on generic drugs in Europe Market forecast to grow to US$21 billion within five years June 2002 Urch Publishing launches comprehensive report on pharmaceutical pricing in Central & Eastern Europe October 2001 Urch Publishing launches comprehensive guide to European pharmaceutical pricing |
|
Top | About Urch | News | Contact | Publications List | Articles | Consulting | © 2008 Urch Publishing | |